The impact of belatacept on third party HLA alloantibodies in highly sensitized kidney transplant recipients

Recent evidence suggests that belatacept reduces the durability of pre-existing antibodies to class I and class II HLA antigens. In this case series of 163 highly-sensitized kidney transplant candidates whose calculated panel reactive antibody (cPRA) activity was ≥98–100%, the impact of belatacept o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Transplant
Päätekijät: Parsons, Ronald F., Zahid, Arslan, Bumb, Shalini, Decker, Hannah, Sullivan, H. Clifford, Lee, F. Eun-Hyung, Badell, I. Raul, Ford, Mandy L., Larsen, Christian P., Pearson, Thomas C., Jackson, Annette M., Chen, Dong-Feng, Levine, Matthew, Kamoun, Malek, Bray, Robert A., Gebel, Howard M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6984982/
https://ncbi.nlm.nih.gov/pubmed/31452332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15585
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia